Basic Search  |  Summaries  |  Advanced Search

Top 5 Offense Groups (Groups Defined)	Penalty Total	Number of Records
competition-related offenses	$1,457,752,500	15
government-contracting-related offenses	$823,474,307	12
healthcare-related offenses	$514,508,250	7
employment-related offenses	$282,061,595	5
financial offenses	$168,500	1

Top 5 Primary Offense Types	Penalty Total	Number of Records
False Claims Act and related	$823,474,307	12
price-fixing or anti-competitive practices	$582,152,500	8
kickbacks and bribery	$504,800,000	4
off-label or unapproved promotion of medical products	$501,638,250	5
Foreign Corrupt Practices Act	$370,800,000	3

Notes: Parent-subsidiary linkages are based on relationships current as of the latest revision listed in the Update Log, which may vary from what was the case when a violation occurred. The penalty totals are adjusted to account for the fact that the individual entries below may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. The totals are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the list below.

Links: Subsidy Tracker data on financial assistance to this company by federal, state and local government agencies can be found here.

For an overview of assistance this company is receiving under the CARES Act, see its Covid Stimulus Watch summary page here.

Individual Penalty Records:

Click on the company or penalty amount for more information on each case.

Company	Primary Offense Type	Year	Agency	Penalty Amount .
Novartis Pharmaceuticals Corporation	False Claims Act and related	2020	DOJ_CIVIL	(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $642,000,000
Novartis Pharmaceuticals Corporation	off-label or unapproved promotion of medical products	2010	FDA	$422,500,000
Novartis Pharmaceuticals	kickbacks and bribery	2015	USAO	$390,000,000
Novartis Hellas S.A.C.I. et al.	Foreign Corrupt Practices Act	2020	DOJ_CRIMINAL	$233,000,000
Sandoz Inc.	price-fixing or anti-competitive practices	2020	DOJ_ANTITRUST	$195,000,000
Sandoz Inc.	False Claims Act and related	2021	DOJ_CIVIL	$185,000,000
Novartis Corporation	employment discrimination	2010	private lawsuit-federal	$175,000,000
Sandoz Inc.	price-fixing or anti-competitive practices	2011	private lawsuit-federal	$150,000,000
Novartis AG	price-fixing or anti-competitive practices	2023	private lawsuit-federal	$126,850,000
Novartis AG	Foreign Corrupt Practices Act	2020	SEC	$112,800,000
Novartis Pharmaceuticals Corp.	kickbacks and bribery	2020	MULTI-AG	$103,000,000
Novartis	wage and hour violation	2012	private lawsuit-federal	$99,000,000
Novartis Pharmaceuticals Corporation	off-label or unapproved promotion of medical products	2010	MULTI-AG	(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $88,258,694
Sandoz Inc.	price-fixing or anti-competitive practices	2020	private lawsuit-federal	$85,000,000
Novartis Pharmaceuticals Corporation	kickbacks and bribery	2015	MULTI-AG	(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $83,129,754
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation	off-label or unapproved promotion of medical products	2010	FDA	$72,500,000
Sandoz, Inc.	False Claims Act and related	2011	MS-AG	$30,110,618
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation	off-label or unapproved promotion of medical products	2010	MULTI-AG	(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $29,000,000
Novartis AG	Foreign Corrupt Practices Act	2016	SEC	$25,000,000
Novartis Pharmaceuticals	False Claims Act and related	2019	IL-AG	$21,280,356
Sandoz	False Claims Act and related	2009	KY-AG	$16,000,000
Geneva Pharmaceuticals	price-fixing or anti-competitive practices	2005	MULTI-AG	$15,350,000
Sandoz	False Claims Act and related	2013	LA-AG	$13,100,000
Sandoz, Inc.	HHS civil monetary penalties	2015	HHSOIG	$12,640,000
Novartis Pharmaceuticals Corporation	kickbacks and bribery	2020	CA-AG	$11,800,000
Novartis Corporation and Alcon Laboratories	employment discrimination	2016	private lawsuit-federal	$8,000,000
Novartis	False Claims Act and related	2013	LA-AG	$7,000,000
Novartis Pharmaceuticals	off-label or unapproved promotion of medical products	2012	TX-AG	$6,638,250
CIBA Vision	price-fixing or anti-competitive practices	2000	MULTI-AG	$5,000,000
Eon Labs Inc.	False Claims Act and related	2010	DOJ_CIVIL	$3,500,000
Novartis Pharmaceuticals Corporation	False Claims Act and related	2010	HI-AG	$3,333,333
Sandoz Inc.	price-fixing or anti-competitive practices	2017	private lawsuit-federal	$3,202,500
Novartis Pharmaceuticals Corp.	False Claims Act and related	2012	KY-AG	$2,750,000
Sandoz Inc.	price-fixing or anti-competitive practices	2017	private lawsuit-federal	$1,750,000
Sandoz Inc.	False Claims Act and related	2010	ID-AG	$1,650,000
Novartis Pharmaceuticals Corp.	False Claims Act and related	2013	ID-AG	$750,000
Sandoz, Inc.	HHS civil monetary penalties	2011	HHSOIG	$230,000
Chiron Corporation Ltd	economic sanction violation	2004	OFAC	$168,500
CHIRON CORPORATION	workplace safety or health violation	2000	OSHA	$90,140
Novartis Pharmaceuticals	employment discrimination	2013	OFCCP	$51,594
NOVARTIS PRODUCTS	environmental violation	2000	EPA	$13,200
NOVARTIS PHARMACEUTICALS CORPORATION	benefit plan administrator violation	2006	EBSA	$10,001
NOVARTIS CONSUMER HEALTH INC.	workplace safety or health violation	2013	OSHA	$6,078
NOVARTIS CONSUMER HEALTH, INC.	environmental violation	2000	EPA	$5,000